Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Scholar

Bioengineering · South Korea · 2025-05-28

Processing Time
249 days
Decision Date
2025-05-28
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop advanced biological tools for genetic and molecular cell interfacing, specifically focusing on high-precision CRISPR base editors and synthetic protein biomarkers. This work aims to refine viral vector delivery systems to enable targeted, non-invasive gene therapies for complex neurological diseases.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical needs in genetic medicine and neurological disease treatment, aligning with U.S. Critical and Emerging Technology priorities.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record in high-impact journals like Science Advances, and significant citation count demonstrate his capability to lead this research.

3 Waiver of Job Offer and Labor Certification Met

The urgency of advancing gene therapy and the petitioner's unique expertise make it beneficial for the U.S. to waive the standard labor certification process.

Why This Petition Was Approved

The petition was approved based on the petitioner's 8 peer-reviewed journal articles, 5 conference abstracts, and 2 patent applications which garnered 163 citations. Evidence showed his work reached the top 1% of cited papers in his field and was supported by funding from the NIH and the Welch Foundation. All three Dhanasar prongs were satisfied through a combination of high-impact research and expert testimonials.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Reference Letters Dependent
Grants
Conference Presentations
Government Alignment

Similar Cases

Research Scientist

Biotechnology · Malaysia

WeGreened EB-2 (NIW) rfe approved
California 216 days 2025-07-17
The petitioner proposes to develop and apply molecular and genome engineering tools, specifically gene-editing technologies, to study and treat human genetic disorders. This work includes managing microbiome-related diseases and enabling precise genetic interventions for patients with rare genetic conditions to advance personalized medicine.
View Case

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 64 days 2025-02-15
The petitioner proposes to develop and implement advanced synthetic biology and genetic engineering techniques to precisely control gene expression and cellular behavior in mammalian cells. Her work aims to enhance therapeutic applications and biotechnological advancements to address critical healthcare challenges, specifically rising cancer rates in the U.S.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Illinois 36 days 2025-09-05
The petitioner proposes to develop cutting-edge genomic technologies to understand the functions of non-coding RNAs. This research aims to uncover their roles in human disease and repurpose them as programmable tools for biotechnology and therapeutic applications.
View Case

Scientist

Biotechnology · Zimbabwe

WeGreened EB-2 (NIW) approved
Massachusetts 297 days 2025-03-06
The petitioner proposes to develop safe and effective gene therapies and delivery systems to improve treatment options for rare and complex disorders. Her work specifically focuses on uncovering how protofibrils contribute to neuronal damage in Alzheimer’s disease to support the development of targeted drug therapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from South Korea

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-28.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 249 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in South Korea All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist